Proprotein Convertase Subtilisin/Kexin Type 9 May Associate With Lipoproteins Through Lipid Interactions

被引：0
|
作者：
Sarkar, Samantha K.
Goto, Natalie
Lagace, Thomas A.
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
PCSK9; LDL; Lipoproteins; Lipids;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19863
引用
收藏
页数：7
相关论文
共 50 条
  • [31] Proprotein convertase subtilisin/kexin type 9 and apelin in fibromyalgia syndrome
    Tas, Nevsun Pihtili
    Baykara, Rabia Aydogan
    Kamanli, Ayhan
    Gurbuz, Ali
    Cure, Erkan
    Cure, Medine Cumhur
    Erdem, Mehmet
    Yildirim, Tugce Tasar
    ARCHIVES OF RHEUMATOLOGY, 2024, 39 (03) : 375 - 383
  • [32] Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Brief Overview
    Noel, Zachary R.
    Beavers, Craig J.
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (02): : 229.e1 - 229.e4
  • [33] Regulation of proprotein convertase subtilisin/kexin type 9: Therapeutical perspectives
    Chan, Dick C.
    ATHEROSCLEROSIS, 2011, 217 (01) : 77 - 79
  • [34] Advances in the field of proprotein convertase subtilisin kexin type 9 inhibitors
    Eisen, Alon
    Giugliano, Robert P.
    CURRENT OPINION IN CARDIOLOGY, 2016, 31 (06) : 644 - 653
  • [35] Proprotein Convertase Subtilisin/kexin Type 9 Interacts and Regulates ApolipoproteinB
    Sun, Hua
    Caskey, C. Thomas
    Teng, Ba-Bie
    CIRCULATION, 2010, 122 (21)
  • [36] Proprotein convertase subtilisin/kexin type 9 in patients with systemic sclerosis
    Ferraz-Amaro, I.
    Delgado-Frias, E.
    Hernandez-Hernandez, V.
    Sanchez-Perez, H.
    de Armas-Rillo, L.
    Garcia-Dopico, J. A.
    Diaz-Gonzalez, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (03) : S18 - S24
  • [37] PROPROTEIN CONVERTASE SUBTILISIN/ KEXIN TYPE 9 LEVELS AND ARTERIAL FUNCTION
    Koutagiar, I.
    Vlachopoulos, C.
    Terentes-Printzios, D.
    Skoumas, J.
    Skliros, N.
    Rigatou, A.
    Ioakeimidis, N.
    Pantou, S.
    Georgakopoulos, C.
    Miliou, A.
    Tousoulis, D.
    ATHEROSCLEROSIS, 2018, 275 : E132 - E132
  • [38] Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition: The Big Step Forward in Lipid Control
    Rikhi, Rishi
    Shapiro, Michael D.
    EUROPEAN CARDIOLOGY REVIEW, 2023, 18
  • [39] Lipid Metabolism: The significance of plasma proprotein convertase subtilisin kexin type 9 in the elucidation of complex lipid disorders
    Brouwers, Martijn C. G. J.
    van Greevenbroek, Marleen M. J.
    CURRENT OPINION IN LIPIDOLOGY, 2011, 22 (04) : 317 - 318
  • [40] AN EVALUATION OF DIFFERENT METHODS TO STUDY THE ASSOCIATION OF PROPROTEIN CONVERTASE SUBTILISIN-KEXIN TYPE 9 TO LIPOPROTEINS.
    Canclini, L.
    Malvandi, A. M.
    Uboldi, P.
    Zampoleri, V.
    Baragetti, A.
    Grigore, L.
    Catapano, A. L.
    ATHEROSCLEROSIS, 2021, 331 : E139 - E139
12345